person · Reporting owner

Ma Jiong

Disclosed activity across 3 companies

Tapewire entity: 45702
SEC CIK: 0001854872

Reported relationships

Latest disclosed role at each company.

Company	Last reported as	Report date	Published
ANAVEX LIFE SCIENCES CORP.AVXL · Entity 6086	Director	March 31, 2025	April 03, 2025
MOBIX LABS, INCMOBX · Entity 7651	Director	October 10, 2022	December 26, 2023
SES AI CorpSES · Entity 2220	Director	May 18, 2026	May 20, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

ANAVEX LIFE SCIENCES CORP.

Report date March 31, 2025 · Filed April 03, 2025

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $8.58 · Expires 2035-03-31	Direct	50,000	Reported balance After 2025-03-31 transaction · row 1 Instrument identity requires review; Table II rows are not merged. 1 source row Row 1 · 2025-03-31 · Grant · Acquired 50,000 · Balance 50,000 F1: The option vests in three equal annual installments beginning on March 31, 2026

Filing footnotes · ownership attribution and instrument terms

F1: The option vests in three equal annual installments beginning on March 31, 2026

MOBIX LABS, INC

Report date October 10, 2022 · Filed December 26, 2023

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Class A Common StockSEC Table I · non-derivative	IndirectSee footnote	1,580,813	Reported balance After 2022-10-10 transaction · row 1 Account identity is unresolved; indirect or unspecified ownership is not merged. 1 source row Row 1 · 2022-10-10 · Other · Disposed 19,000 · Balance 1,580,813 F1: Pursuant to the Issuer's de-registration as a Cayman Islands exempted company and domestication as a Delaware corporation (the "Domestication") in connection with the closing (the "Closing") of the Issuer's initial business combination (the "Business Combination"; the Issuer prior to the Domestication, "Chavant") with Mobix Labs, Inc. (the "Target") on December 21, 2023, each ordinary share of Chavant ("Ordinary Share") and each private placement warrant, exercisable to purchase one Ordinary Share for $11.50 per share, subject to certain adjustments, of Chavant ("Chavant Private Placement Warrants") was automatically converted into one share of Class A Common Stock of the Issuer ("Class A Common Stock") and one private placement warrant, exercisable to purchase one share of Class A Common Stock for $11.50 per share, subject to certain adjustments, of the Issuer ("Private Placement Warrants"), respectively. In connection with the Closing, Chavant was renamed "Mobix Labs, Inc." F2: Represents a transfer of interests in Chavant Capital Partners LLC (the "Sponsor") by the Reporting Person to another member of the Sponsor in connection with such other member's agreement to fund certain amounts to the Sponsor in order to permit it to make certain loans to the Issuer. Does not represent any transfer of Ordinary Shares then held by the Sponsor, and prior to and following such transfers, the Sponsor continued to hold 1,580,813 Ordinary Shares. F3: The Sponsor is the record holder of the securities reported herein. The Reporting Person is the sole member of the manager of the Sponsor and has voting and investment discretion with respect to the securities held of record by the Sponsor. The Reporting Person disclaims any beneficial ownership of the securities held by the Sponsor other than to the extent of any pecuniary interest she may have therein, directly or indirectly.
Class A Common StockSEC Table I · non-derivative	IndirectSee footnote	1,580,813	Reported balance After 2023-01-06 transaction · row 2 Account identity is unresolved; indirect or unspecified ownership is not merged. 1 source row Row 2 · 2023-01-06 · Other · Disposed 20,000 · Balance 1,580,813 F1: Pursuant to the Issuer's de-registration as a Cayman Islands exempted company and domestication as a Delaware corporation (the "Domestication") in connection with the closing (the "Closing") of the Issuer's initial business combination (the "Business Combination"; the Issuer prior to the Domestication, "Chavant") with Mobix Labs, Inc. (the "Target") on December 21, 2023, each ordinary share of Chavant ("Ordinary Share") and each private placement warrant, exercisable to purchase one Ordinary Share for $11.50 per share, subject to certain adjustments, of Chavant ("Chavant Private Placement Warrants") was automatically converted into one share of Class A Common Stock of the Issuer ("Class A Common Stock") and one private placement warrant, exercisable to purchase one share of Class A Common Stock for $11.50 per share, subject to certain adjustments, of the Issuer ("Private Placement Warrants"), respectively. In connection with the Closing, Chavant was renamed "Mobix Labs, Inc." F2: Represents a transfer of interests in Chavant Capital Partners LLC (the "Sponsor") by the Reporting Person to another member of the Sponsor in connection with such other member's agreement to fund certain amounts to the Sponsor in order to permit it to make certain loans to the Issuer. Does not represent any transfer of Ordinary Shares then held by the Sponsor, and prior to and following such transfers, the Sponsor continued to hold 1,580,813 Ordinary Shares. F3: The Sponsor is the record holder of the securities reported herein. The Reporting Person is the sole member of the manager of the Sponsor and has voting and investment discretion with respect to the securities held of record by the Sponsor. The Reporting Person disclaims any beneficial ownership of the securities held by the Sponsor other than to the extent of any pecuniary interest she may have therein, directly or indirectly.
Class A Common StockSEC Table I · non-derivative	IndirectSee footnote	1,121,919	Reported balance After 2023-12-21 transaction · row 3 Account identity is unresolved; indirect or unspecified ownership is not merged. 1 source row Row 3 · 2023-12-21 · Grant · Acquired 199,737 · Balance 1,121,919 F1: Pursuant to the Issuer's de-registration as a Cayman Islands exempted company and domestication as a Delaware corporation (the "Domestication") in connection with the closing (the "Closing") of the Issuer's initial business combination (the "Business Combination"; the Issuer prior to the Domestication, "Chavant") with Mobix Labs, Inc. (the "Target") on December 21, 2023, each ordinary share of Chavant ("Ordinary Share") and each private placement warrant, exercisable to purchase one Ordinary Share for $11.50 per share, subject to certain adjustments, of Chavant ("Chavant Private Placement Warrants") was automatically converted into one share of Class A Common Stock of the Issuer ("Class A Common Stock") and one private placement warrant, exercisable to purchase one share of Class A Common Stock for $11.50 per share, subject to certain adjustments, of the Issuer ("Private Placement Warrants"), respectively. In connection with the Closing, Chavant was renamed "Mobix Labs, Inc." F4: Pursuant to a Subscription Agreement, the Sponsor purchased 199,737 shares of Class A Common Stock in connection with the Closing for aggregate consideration of $1,997,370, consisting of the forgiveness of certain indebtedness and certain expense reimbursement obligations owed by the Issuer to the Sponsor and its members (the "PIPE Investment" and such shares, the "PIPE Shares"). In connection with the entry into the Subscription Agreement, the Target issued to the Sponsor a warrant to purchase 272,4454 shares of common stock of the Target. Such warrant was net exercised for 272,182 shares of common stock of the Target in connection with the closing of the Subscription Agreement, which occurred substantially concurrently with the Closing. Such 272,454 shares of common stock of the Target were automatically converted into 272,182 shares of Class A Common Stock upon the Closing. F5: Reflects a forfeiture of 658,631 Ordinary Shares held by the Sponsor in connection with the Closing (the "Share Forfeiture"), none of which were indirectly beneficially owned by the Reporting Person. F3: The Sponsor is the record holder of the securities reported herein. The Reporting Person is the sole member of the manager of the Sponsor and has voting and investment discretion with respect to the securities held of record by the Sponsor. The Reporting Person disclaims any beneficial ownership of the securities held by the Sponsor other than to the extent of any pecuniary interest she may have therein, directly or indirectly.
Class A Common StockSEC Table I · non-derivative	IndirectSee footnote	1,394,101	Reported balance After 2023-12-21 transaction · row 4 Account identity is unresolved; indirect or unspecified ownership is not merged. 1 source row Row 4 · 2023-12-21 · Grant · Acquired 272,182 · Balance 1,394,101 F1: Pursuant to the Issuer's de-registration as a Cayman Islands exempted company and domestication as a Delaware corporation (the "Domestication") in connection with the closing (the "Closing") of the Issuer's initial business combination (the "Business Combination"; the Issuer prior to the Domestication, "Chavant") with Mobix Labs, Inc. (the "Target") on December 21, 2023, each ordinary share of Chavant ("Ordinary Share") and each private placement warrant, exercisable to purchase one Ordinary Share for $11.50 per share, subject to certain adjustments, of Chavant ("Chavant Private Placement Warrants") was automatically converted into one share of Class A Common Stock of the Issuer ("Class A Common Stock") and one private placement warrant, exercisable to purchase one share of Class A Common Stock for $11.50 per share, subject to certain adjustments, of the Issuer ("Private Placement Warrants"), respectively. In connection with the Closing, Chavant was renamed "Mobix Labs, Inc." F4: Pursuant to a Subscription Agreement, the Sponsor purchased 199,737 shares of Class A Common Stock in connection with the Closing for aggregate consideration of $1,997,370, consisting of the forgiveness of certain indebtedness and certain expense reimbursement obligations owed by the Issuer to the Sponsor and its members (the "PIPE Investment" and such shares, the "PIPE Shares"). In connection with the entry into the Subscription Agreement, the Target issued to the Sponsor a warrant to purchase 272,4454 shares of common stock of the Target. Such warrant was net exercised for 272,182 shares of common stock of the Target in connection with the closing of the Subscription Agreement, which occurred substantially concurrently with the Closing. Such 272,454 shares of common stock of the Target were automatically converted into 272,182 shares of Class A Common Stock upon the Closing. F3: The Sponsor is the record holder of the securities reported herein. The Reporting Person is the sole member of the manager of the Sponsor and has voting and investment discretion with respect to the securities held of record by the Sponsor. The Reporting Person disclaims any beneficial ownership of the securities held by the Sponsor other than to the extent of any pecuniary interest she may have therein, directly or indirectly.
Private Placement WarrantsSEC Table II · derivative / convertible security · Conversion / exercise price $11.50 · Expires 2028-12-21	IndirectSee footnote	1,241,552	Reported balance After 2023-12-21 transaction · row 5 Instrument identity requires review; Table II rows are not merged. 1 source row Row 5 · 2023-12-21 · Grant · Acquired 1,241,552 · Balance 1,241,552 F1: Pursuant to the Issuer's de-registration as a Cayman Islands exempted company and domestication as a Delaware corporation (the "Domestication") in connection with the closing (the "Closing") of the Issuer's initial business combination (the "Business Combination"; the Issuer prior to the Domestication, "Chavant") with Mobix Labs, Inc. (the "Target") on December 21, 2023, each ordinary share of Chavant ("Ordinary Share") and each private placement warrant, exercisable to purchase one Ordinary Share for $11.50 per share, subject to certain adjustments, of Chavant ("Chavant Private Placement Warrants") was automatically converted into one share of Class A Common Stock of the Issuer ("Class A Common Stock") and one private placement warrant, exercisable to purchase one share of Class A Common Stock for $11.50 per share, subject to certain adjustments, of the Issuer ("Private Placement Warrants"), respectively. In connection with the Closing, Chavant was renamed "Mobix Labs, Inc." F6: Represents Private Placement Warrants held by the Sponsor since the initial public offering of Chavant, which were distributed by the Sponsor to its members as a pro rata distribution in respect of their respective indirect interests in such Private Placement Warrants and are now held by the Reporting Person indirectly through a wholly-owned limited liability company. Private Placement Warrants may be exercised 30 days after the Closing and expire five years after Closing or earlier upon liquidation. F7: Securities are held by the Reporting Person through a wholly-owned limited liability company.
Make-Whole Shares (right to acquire)SEC Table II · derivative / convertible security · Conversion / exercise price $10.00	IndirectSee footnote	199,737	Reported balance After 2023-12-21 transaction · row 6 Instrument identity requires review; Table II rows are not merged. 1 source row Row 6 · 2023-12-21 · Grant · Acquired 199,737 · Balance 199,737 F8: Pursuant to the Subscription Agreement for the PIPE Investment, the Issuer has agreed to issue additional shares of Class A Common Stock if the volume weighted average price per share of Class A Common Stock during the 30-day period (the "Adjustment Period") commencing on the date that is 30 days after the date on which a resale Registration Statement relating to the PIPE Investment is declared effective (the "Adjustment Period VWAP") is less than $10.00 per share. In such case, the Sponsor will be entitled to receive a number of shares of Class A Common Stock equal to the product of (x) the number of PIPE Shares held by the Sponsor through the end of the Adjustment Period multiplied by (y) a fraction, (A) the numerator of which is $10.00 minus the Adjustment Period VWAP and (B) the denominator of which is the Adjustment Period VWAP (the "Make-Whole Shares"). In the event that the Adjustment Period VWAP is less than $7.00, the Adjustment Period VWAP will be deemed to be $7.00. F4: Pursuant to a Subscription Agreement, the Sponsor purchased 199,737 shares of Class A Common Stock in connection with the Closing for aggregate consideration of $1,997,370, consisting of the forgiveness of certain indebtedness and certain expense reimbursement obligations owed by the Issuer to the Sponsor and its members (the "PIPE Investment" and such shares, the "PIPE Shares"). In connection with the entry into the Subscription Agreement, the Target issued to the Sponsor a warrant to purchase 272,4454 shares of common stock of the Target. Such warrant was net exercised for 272,182 shares of common stock of the Target in connection with the closing of the Subscription Agreement, which occurred substantially concurrently with the Closing. Such 272,454 shares of common stock of the Target were automatically converted into 272,182 shares of Class A Common Stock upon the Closing. F3: The Sponsor is the record holder of the securities reported herein. The Reporting Person is the sole member of the manager of the Sponsor and has voting and investment discretion with respect to the securities held of record by the Sponsor. The Reporting Person disclaims any beneficial ownership of the securities held by the Sponsor other than to the extent of any pecuniary interest she may have therein, directly or indirectly.

Filing footnotes · ownership attribution and instrument terms

F1: Pursuant to the Issuer's de-registration as a Cayman Islands exempted company and domestication as a Delaware corporation (the "Domestication") in connection with the closing (the "Closing") of the Issuer's initial business combination (the "Business Combination"; the Issuer prior to the Domestication, "Chavant") with Mobix Labs, Inc. (the "Target") on December 21, 2023, each ordinary share of Chavant ("Ordinary Share") and each private placement warrant, exercisable to purchase one Ordinary Share for $11.50 per share, subject to certain adjustments, of Chavant ("Chavant Private Placement Warrants") was automatically converted into one share of Class A Common Stock of the Issuer ("Class A Common Stock") and one private placement warrant, exercisable to purchase one share of Class A Common Stock for $11.50 per share, subject to certain adjustments, of the Issuer ("Private Placement Warrants"), respectively. In connection with the Closing, Chavant was renamed "Mobix Labs, Inc."

F2: Represents a transfer of interests in Chavant Capital Partners LLC (the "Sponsor") by the Reporting Person to another member of the Sponsor in connection with such other member's agreement to fund certain amounts to the Sponsor in order to permit it to make certain loans to the Issuer. Does not represent any transfer of Ordinary Shares then held by the Sponsor, and prior to and following such transfers, the Sponsor continued to hold 1,580,813 Ordinary Shares.

F3: The Sponsor is the record holder of the securities reported herein. The Reporting Person is the sole member of the manager of the Sponsor and has voting and investment discretion with respect to the securities held of record by the Sponsor. The Reporting Person disclaims any beneficial ownership of the securities held by the Sponsor other than to the extent of any pecuniary interest she may have therein, directly or indirectly.

F4: Pursuant to a Subscription Agreement, the Sponsor purchased 199,737 shares of Class A Common Stock in connection with the Closing for aggregate consideration of $1,997,370, consisting of the forgiveness of certain indebtedness and certain expense reimbursement obligations owed by the Issuer to the Sponsor and its members (the "PIPE Investment" and such shares, the "PIPE Shares"). In connection with the entry into the Subscription Agreement, the Target issued to the Sponsor a warrant to purchase 272,4454 shares of common stock of the Target. Such warrant was net exercised for 272,182 shares of common stock of the Target in connection with the closing of the Subscription Agreement, which occurred substantially concurrently with the Closing. Such 272,454 shares of common stock of the Target were automatically converted into 272,182 shares of Class A Common Stock upon the Closing.

F5: Reflects a forfeiture of 658,631 Ordinary Shares held by the Sponsor in connection with the Closing (the "Share Forfeiture"), none of which were indirectly beneficially owned by the Reporting Person.

F6: Represents Private Placement Warrants held by the Sponsor since the initial public offering of Chavant, which were distributed by the Sponsor to its members as a pro rata distribution in respect of their respective indirect interests in such Private Placement Warrants and are now held by the Reporting Person indirectly through a wholly-owned limited liability company. Private Placement Warrants may be exercised 30 days after the Closing and expire five years after Closing or earlier upon liquidation.

F7: Securities are held by the Reporting Person through a wholly-owned limited liability company.

F8: Pursuant to the Subscription Agreement for the PIPE Investment, the Issuer has agreed to issue additional shares of Class A Common Stock if the volume weighted average price per share of Class A Common Stock during the 30-day period (the "Adjustment Period") commencing on the date that is 30 days after the date on which a resale Registration Statement relating to the PIPE Investment is declared effective (the "Adjustment Period VWAP") is less than $10.00 per share. In such case, the Sponsor will be entitled to receive a number of shares of Class A Common Stock equal to the product of (x) the number of PIPE Shares held by the Sponsor through the end of the Adjustment Period multiplied by (y) a fraction, (A) the numerator of which is $10.00 minus the Adjustment Period VWAP and (B) the denominator of which is the Adjustment Period VWAP (the "Make-Whole Shares"). In the event that the Adjustment Period VWAP is less than $7.00, the Adjustment Period VWAP will be deemed to be $7.00.

SES AI Corp

Report date May 18, 2026 · Filed May 20, 2026

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Class A Common StockSEC Table I · non-derivative	Direct	524,993	Reported balance After 2026-05-18 transaction · row 1 1 source row Row 1 · 2026-05-18 · Grant · Acquired 141,593 · Balance 524,993 F1: Represents shares of Class A common stock, par value $0.0001 per share ("Class A Common Stock"), underlying restricted stock units ("RSUs") granted to the reporting person on May 18, 2026 (the "Grant Date") pursuant to the Issuer's 2021 Incentive Award Plan. The RSUs will vest in full, and an equal number of shares of Class A Common Stock will be deliverable to the reporting person, on the first anniversary of the Grant Date, subject to continued service through such vesting date.

Filing footnotes · ownership attribution and instrument terms

F1: Represents shares of Class A common stock, par value $0.0001 per share ("Class A Common Stock"), underlying restricted stock units ("RSUs") granted to the reporting person on May 18, 2026 (the "Grant Date") pursuant to the Issuer's 2021 Incentive Award Plan. The RSUs will vest in full, and an equal number of shares of Class A Common Stock will be deliverable to the reporting person, on the first anniversary of the Grant Date, subject to continued service through such vesting date.

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
May 18, 2026 Filed May 20, 2026 21:30 UTC	SES AI Corp SES · Entity 2220	GrantClass A Common Stock	141,593	$0.00	$0.00	Disclosure SEC source: 0001854872-26-000002 · form4-05202026_050501.xml · nonDerivative · entry 1 Ma Jiong · CIK 0001854872 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 524,993 F1 · kind: Represents shares of Class A common stock, par value $0.0001 per share ("Class A Common Stock"), underlying restricted stock units ("RSUs") granted to the reporting person on May 18, 2026 (the "Grant Date") pursuant to the Issuer's 2021 Incentive Award Plan. The RSUs will vest in full, and an equal number of shares of Class A Common Stock will be deliverable to the reporting person, on the first anniversary of the Grant Date, subject to continued service through such vesting date. F1 · shares: Represents shares of Class A common stock, par value $0.0001 per share ("Class A Common Stock"), underlying restricted stock units ("RSUs") granted to the reporting person on May 18, 2026 (the "Grant Date") pursuant to the Issuer's 2021 Incentive Award Plan. The RSUs will vest in full, and an equal number of shares of Class A Common Stock will be deliverable to the reporting person, on the first anniversary of the Grant Date, subject to continued service through such vesting date. Read SEC document
March 31, 2025 Filed Apr 3, 2025 01:46 UTC	ANAVEX LIFE SCIENCES CORP. AVXL · Entity 6086	GrantStock Option (Right to Buy) · Derivative	50,000	$0.00 Strike: $8.58	$0.00	Disclosure SEC source: 0001731122-25-000517 · ownership.xml · derivative · entry 1 Ma Jiong · CIK 0001854872 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2035-03-31 F1 · derivative.exercise_date: The option vests in three equal annual installments beginning on March 31, 2026 Read SEC document
March 28, 2025 Filed Apr 1, 2025 23:52 UTC	SES AI Corp SES · Entity 2220	GrantClass A Common Stock	160,000	$0.00	$0.00	Disclosure SEC source: 0001415889-25-009448 · form4-04012025_110425.xml · nonDerivative · entry 1 Ma Jiong · CIK 0001854872 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 383,400 F1 · shares: Represents shares of Class A common stock, par value $0.0001 per share ("Class A Common Stock"), underlying restricted stock units ("RSUs") granted to the reporting person on March 28, 2025 (the "Grant Date") pursuant to the Issuer's 2021 Incentive Award Plan. The RSUs will vest in full, and an equal number of shares of Class A Common Stock will be deliverable to the reporting person, on the first anniversary of the Grant Date, subject to continued service through such vesting date. Read SEC document
February 20, 2024 Filed Feb 23, 2024 11:03 UTC	ANAVEX LIFE SCIENCES CORP. AVXL · Entity 6086	GrantStock Option (Right to Buy) · Derivative	50,000	$0.00 Strike: $5.36	$0.00	Disclosure SEC source: 0001731122-24-000294 · ownership.xml · derivative · entry 1 Ma Jiong · CIK 0001854872 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2034-02-20 F1 · derivative.exercise_date: Options vest in equal installments over three years from the grant date. Read SEC document
February 06, 2024 Filed Feb 8, 2024 22:25 UTC	SES AI Corp SES · Entity 2220	GrantClass A Common Stock	127,119	$0.00	$0.00	Disclosure SEC source: 0001415889-24-003048 · form4-02082024_050202.xml · nonDerivative · entry 1 Ma Jiong · CIK 0001854872 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 223,400 F1 · shares: Represents shares of Class A common stock, par value $0.0001 per share ("Class A Common Stock"), underlying restricted stock units ("RSUs") granted to the reporting person on February 6, 2024 (the "Grant Date") pursuant to the Issuer's 2021 Incentive Award Plan. The RSUs will vest in full, and an equal number of shares of Class A Common Stock will be deliverable to the reporting person, on the first anniversary of the Grant Date, subject to continued service through such vesting date. F2 · balance_after: Includes 189,881 shares of Class A Common Stock underlying RSUs, which are subject to forfeiture until they vest. Read SEC document
December 21, 2023 Filed Dec 26, 2023 22:58 UTC	MOBIX LABS, INC MOBX · Entity 7651	GrantMake-Whole Shares (right to acquire) · Derivative	199,737	Not disclosed Strike: $10.00	Not disclosed	Disclosure SEC source: 0001104659-23-129310 · tm2333669-17_4seq1.xml · derivative · entry 6 Ma Jiong · CIK 0001854872 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 199,737 Underlying: Class A Common Stock · 199,737 shares Expires not disclosed F8 · kind: Pursuant to the Subscription Agreement for the PIPE Investment, the Issuer has agreed to issue additional shares of Class A Common Stock if the volume weighted average price per share of Class A Common Stock during the 30-day period (the "Adjustment Period") commencing on the date that is 30 days after the date on which a resale Registration Statement relating to the PIPE Investment is declared effective (the "Adjustment Period VWAP") is less than $10.00 per share. In such case, the Sponsor will be entitled to receive a number of shares of Class A Common Stock equal to the product of (x) the number of PIPE Shares held by the Sponsor through the end of the Adjustment Period multiplied by (y) a fraction, (A) the numerator of which is $10.00 minus the Adjustment Period VWAP and (B) the denominator of which is the Adjustment Period VWAP (the "Make-Whole Shares"). In the event that the Adjustment Period VWAP is less than $7.00, the Adjustment Period VWAP will be deemed to be $7.00. F4 · price: Pursuant to a Subscription Agreement, the Sponsor purchased 199,737 shares of Class A Common Stock in connection with the Closing for aggregate consideration of $1,997,370, consisting of the forgiveness of certain indebtedness and certain expense reimbursement obligations owed by the Issuer to the Sponsor and its members (the "PIPE Investment" and such shares, the "PIPE Shares"). In connection with the entry into the Subscription Agreement, the Target issued to the Sponsor a warrant to purchase 272,4454 shares of common stock of the Target. Such warrant was net exercised for 272,182 shares of common stock of the Target in connection with the closing of the Subscription Agreement, which occurred substantially concurrently with the Closing. Such 272,454 shares of common stock of the Target were automatically converted into 272,182 shares of Class A Common Stock upon the Closing. F8 · price: Pursuant to the Subscription Agreement for the PIPE Investment, the Issuer has agreed to issue additional shares of Class A Common Stock if the volume weighted average price per share of Class A Common Stock during the 30-day period (the "Adjustment Period") commencing on the date that is 30 days after the date on which a resale Registration Statement relating to the PIPE Investment is declared effective (the "Adjustment Period VWAP") is less than $10.00 per share. In such case, the Sponsor will be entitled to receive a number of shares of Class A Common Stock equal to the product of (x) the number of PIPE Shares held by the Sponsor through the end of the Adjustment Period multiplied by (y) a fraction, (A) the numerator of which is $10.00 minus the Adjustment Period VWAP and (B) the denominator of which is the Adjustment Period VWAP (the "Make-Whole Shares"). In the event that the Adjustment Period VWAP is less than $7.00, the Adjustment Period VWAP will be deemed to be $7.00. F8 · derivative.exercise_date: Pursuant to the Subscription Agreement for the PIPE Investment, the Issuer has agreed to issue additional shares of Class A Common Stock if the volume weighted average price per share of Class A Common Stock during the 30-day period (the "Adjustment Period") commencing on the date that is 30 days after the date on which a resale Registration Statement relating to the PIPE Investment is declared effective (the "Adjustment Period VWAP") is less than $10.00 per share. In such case, the Sponsor will be entitled to receive a number of shares of Class A Common Stock equal to the product of (x) the number of PIPE Shares held by the Sponsor through the end of the Adjustment Period multiplied by (y) a fraction, (A) the numerator of which is $10.00 minus the Adjustment Period VWAP and (B) the denominator of which is the Adjustment Period VWAP (the "Make-Whole Shares"). In the event that the Adjustment Period VWAP is less than $7.00, the Adjustment Period VWAP will be deemed to be $7.00. F8 · derivative.expiration_date: Pursuant to the Subscription Agreement for the PIPE Investment, the Issuer has agreed to issue additional shares of Class A Common Stock if the volume weighted average price per share of Class A Common Stock during the 30-day period (the "Adjustment Period") commencing on the date that is 30 days after the date on which a resale Registration Statement relating to the PIPE Investment is declared effective (the "Adjustment Period VWAP") is less than $10.00 per share. In such case, the Sponsor will be entitled to receive a number of shares of Class A Common Stock equal to the product of (x) the number of PIPE Shares held by the Sponsor through the end of the Adjustment Period multiplied by (y) a fraction, (A) the numerator of which is $10.00 minus the Adjustment Period VWAP and (B) the denominator of which is the Adjustment Period VWAP (the "Make-Whole Shares"). In the event that the Adjustment Period VWAP is less than $7.00, the Adjustment Period VWAP will be deemed to be $7.00. F8 · derivative.underlying_shares: Pursuant to the Subscription Agreement for the PIPE Investment, the Issuer has agreed to issue additional shares of Class A Common Stock if the volume weighted average price per share of Class A Common Stock during the 30-day period (the "Adjustment Period") commencing on the date that is 30 days after the date on which a resale Registration Statement relating to the PIPE Investment is declared effective (the "Adjustment Period VWAP") is less than $10.00 per share. In such case, the Sponsor will be entitled to receive a number of shares of Class A Common Stock equal to the product of (x) the number of PIPE Shares held by the Sponsor through the end of the Adjustment Period multiplied by (y) a fraction, (A) the numerator of which is $10.00 minus the Adjustment Period VWAP and (B) the denominator of which is the Adjustment Period VWAP (the "Make-Whole Shares"). In the event that the Adjustment Period VWAP is less than $7.00, the Adjustment Period VWAP will be deemed to be $7.00. F3 · ownership.nature: The Sponsor is the record holder of the securities reported herein. The Reporting Person is the sole member of the manager of the Sponsor and has voting and investment discretion with respect to the securities held of record by the Sponsor. The Reporting Person disclaims any beneficial ownership of the securities held by the Sponsor other than to the extent of any pecuniary interest she may have therein, directly or indirectly. Read SEC document
December 21, 2023 Filed Dec 26, 2023 22:58 UTC	MOBIX LABS, INC MOBX · Entity 7651	GrantPrivate Placement Warrants · Derivative	1,241,552	Not disclosed Strike: $11.50	Not disclosed	Disclosure SEC source: 0001104659-23-129310 · tm2333669-17_4seq1.xml · derivative · entry 5 Ma Jiong · CIK 0001854872 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 1,241,552 Underlying: Class A Common Stock · 1,241,552 shares Expires 2028-12-21 F1 · security: Pursuant to the Issuer's de-registration as a Cayman Islands exempted company and domestication as a Delaware corporation (the "Domestication") in connection with the closing (the "Closing") of the Issuer's initial business combination (the "Business Combination"; the Issuer prior to the Domestication, "Chavant") with Mobix Labs, Inc. (the "Target") on December 21, 2023, each ordinary share of Chavant ("Ordinary Share") and each private placement warrant, exercisable to purchase one Ordinary Share for $11.50 per share, subject to certain adjustments, of Chavant ("Chavant Private Placement Warrants") was automatically converted into one share of Class A Common Stock of the Issuer ("Class A Common Stock") and one private placement warrant, exercisable to purchase one share of Class A Common Stock for $11.50 per share, subject to certain adjustments, of the Issuer ("Private Placement Warrants"), respectively. In connection with the Closing, Chavant was renamed "Mobix Labs, Inc." F6 · kind: Represents Private Placement Warrants held by the Sponsor since the initial public offering of Chavant, which were distributed by the Sponsor to its members as a pro rata distribution in respect of their respective indirect interests in such Private Placement Warrants and are now held by the Reporting Person indirectly through a wholly-owned limited liability company. Private Placement Warrants may be exercised 30 days after the Closing and expire five years after Closing or earlier upon liquidation. F6 · price: Represents Private Placement Warrants held by the Sponsor since the initial public offering of Chavant, which were distributed by the Sponsor to its members as a pro rata distribution in respect of their respective indirect interests in such Private Placement Warrants and are now held by the Reporting Person indirectly through a wholly-owned limited liability company. Private Placement Warrants may be exercised 30 days after the Closing and expire five years after Closing or earlier upon liquidation. F1 · derivative.underlying_shares: Pursuant to the Issuer's de-registration as a Cayman Islands exempted company and domestication as a Delaware corporation (the "Domestication") in connection with the closing (the "Closing") of the Issuer's initial business combination (the "Business Combination"; the Issuer prior to the Domestication, "Chavant") with Mobix Labs, Inc. (the "Target") on December 21, 2023, each ordinary share of Chavant ("Ordinary Share") and each private placement warrant, exercisable to purchase one Ordinary Share for $11.50 per share, subject to certain adjustments, of Chavant ("Chavant Private Placement Warrants") was automatically converted into one share of Class A Common Stock of the Issuer ("Class A Common Stock") and one private placement warrant, exercisable to purchase one share of Class A Common Stock for $11.50 per share, subject to certain adjustments, of the Issuer ("Private Placement Warrants"), respectively. In connection with the Closing, Chavant was renamed "Mobix Labs, Inc." F7 · ownership.nature: Securities are held by the Reporting Person through a wholly-owned limited liability company. Read SEC document
December 21, 2023 Filed Dec 26, 2023 22:58 UTC	MOBIX LABS, INC MOBX · Entity 7651	GrantClass A Common Stock	272,182	Not disclosed	Not disclosed	Disclosure SEC source: 0001104659-23-129310 · tm2333669-17_4seq1.xml · nonDerivative · entry 4 Ma Jiong · CIK 0001854872 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 1,394,101 F1 · security: Pursuant to the Issuer's de-registration as a Cayman Islands exempted company and domestication as a Delaware corporation (the "Domestication") in connection with the closing (the "Closing") of the Issuer's initial business combination (the "Business Combination"; the Issuer prior to the Domestication, "Chavant") with Mobix Labs, Inc. (the "Target") on December 21, 2023, each ordinary share of Chavant ("Ordinary Share") and each private placement warrant, exercisable to purchase one Ordinary Share for $11.50 per share, subject to certain adjustments, of Chavant ("Chavant Private Placement Warrants") was automatically converted into one share of Class A Common Stock of the Issuer ("Class A Common Stock") and one private placement warrant, exercisable to purchase one share of Class A Common Stock for $11.50 per share, subject to certain adjustments, of the Issuer ("Private Placement Warrants"), respectively. In connection with the Closing, Chavant was renamed "Mobix Labs, Inc." F4 · kind: Pursuant to a Subscription Agreement, the Sponsor purchased 199,737 shares of Class A Common Stock in connection with the Closing for aggregate consideration of $1,997,370, consisting of the forgiveness of certain indebtedness and certain expense reimbursement obligations owed by the Issuer to the Sponsor and its members (the "PIPE Investment" and such shares, the "PIPE Shares"). In connection with the entry into the Subscription Agreement, the Target issued to the Sponsor a warrant to purchase 272,4454 shares of common stock of the Target. Such warrant was net exercised for 272,182 shares of common stock of the Target in connection with the closing of the Subscription Agreement, which occurred substantially concurrently with the Closing. Such 272,454 shares of common stock of the Target were automatically converted into 272,182 shares of Class A Common Stock upon the Closing. F4 · price: Pursuant to a Subscription Agreement, the Sponsor purchased 199,737 shares of Class A Common Stock in connection with the Closing for aggregate consideration of $1,997,370, consisting of the forgiveness of certain indebtedness and certain expense reimbursement obligations owed by the Issuer to the Sponsor and its members (the "PIPE Investment" and such shares, the "PIPE Shares"). In connection with the entry into the Subscription Agreement, the Target issued to the Sponsor a warrant to purchase 272,4454 shares of common stock of the Target. Such warrant was net exercised for 272,182 shares of common stock of the Target in connection with the closing of the Subscription Agreement, which occurred substantially concurrently with the Closing. Such 272,454 shares of common stock of the Target were automatically converted into 272,182 shares of Class A Common Stock upon the Closing. F3 · ownership.nature: The Sponsor is the record holder of the securities reported herein. The Reporting Person is the sole member of the manager of the Sponsor and has voting and investment discretion with respect to the securities held of record by the Sponsor. The Reporting Person disclaims any beneficial ownership of the securities held by the Sponsor other than to the extent of any pecuniary interest she may have therein, directly or indirectly. Read SEC document
December 21, 2023 Filed Dec 26, 2023 22:58 UTC	MOBIX LABS, INC MOBX · Entity 7651	GrantClass A Common Stock	199,737	$10.00	$1,997,370.00	Disclosure SEC source: 0001104659-23-129310 · tm2333669-17_4seq1.xml · nonDerivative · entry 3 Ma Jiong · CIK 0001854872 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 1,121,919 F1 · security: Pursuant to the Issuer's de-registration as a Cayman Islands exempted company and domestication as a Delaware corporation (the "Domestication") in connection with the closing (the "Closing") of the Issuer's initial business combination (the "Business Combination"; the Issuer prior to the Domestication, "Chavant") with Mobix Labs, Inc. (the "Target") on December 21, 2023, each ordinary share of Chavant ("Ordinary Share") and each private placement warrant, exercisable to purchase one Ordinary Share for $11.50 per share, subject to certain adjustments, of Chavant ("Chavant Private Placement Warrants") was automatically converted into one share of Class A Common Stock of the Issuer ("Class A Common Stock") and one private placement warrant, exercisable to purchase one share of Class A Common Stock for $11.50 per share, subject to certain adjustments, of the Issuer ("Private Placement Warrants"), respectively. In connection with the Closing, Chavant was renamed "Mobix Labs, Inc." F4 · kind: Pursuant to a Subscription Agreement, the Sponsor purchased 199,737 shares of Class A Common Stock in connection with the Closing for aggregate consideration of $1,997,370, consisting of the forgiveness of certain indebtedness and certain expense reimbursement obligations owed by the Issuer to the Sponsor and its members (the "PIPE Investment" and such shares, the "PIPE Shares"). In connection with the entry into the Subscription Agreement, the Target issued to the Sponsor a warrant to purchase 272,4454 shares of common stock of the Target. Such warrant was net exercised for 272,182 shares of common stock of the Target in connection with the closing of the Subscription Agreement, which occurred substantially concurrently with the Closing. Such 272,454 shares of common stock of the Target were automatically converted into 272,182 shares of Class A Common Stock upon the Closing. F4 · price: Pursuant to a Subscription Agreement, the Sponsor purchased 199,737 shares of Class A Common Stock in connection with the Closing for aggregate consideration of $1,997,370, consisting of the forgiveness of certain indebtedness and certain expense reimbursement obligations owed by the Issuer to the Sponsor and its members (the "PIPE Investment" and such shares, the "PIPE Shares"). In connection with the entry into the Subscription Agreement, the Target issued to the Sponsor a warrant to purchase 272,4454 shares of common stock of the Target. Such warrant was net exercised for 272,182 shares of common stock of the Target in connection with the closing of the Subscription Agreement, which occurred substantially concurrently with the Closing. Such 272,454 shares of common stock of the Target were automatically converted into 272,182 shares of Class A Common Stock upon the Closing. F5 · balance_after: Reflects a forfeiture of 658,631 Ordinary Shares held by the Sponsor in connection with the Closing (the "Share Forfeiture"), none of which were indirectly beneficially owned by the Reporting Person. F3 · ownership.nature: The Sponsor is the record holder of the securities reported herein. The Reporting Person is the sole member of the manager of the Sponsor and has voting and investment discretion with respect to the securities held of record by the Sponsor. The Reporting Person disclaims any beneficial ownership of the securities held by the Sponsor other than to the extent of any pecuniary interest she may have therein, directly or indirectly. Read SEC document
April 14, 2023 Filed Apr 18, 2023 22:00 UTC	SES AI Corp SES · Entity 2220	GrantClass A Common Stock	62,762	$0.00	$0.00	Disclosure SEC source: 0001415889-23-006622 · form4-04182023_060404.xml · nonDerivative · entry 1 Ma Jiong · CIK 0001854872 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 96,281 F1 · shares: Represents shares of Class A common stock, par value $0.0001 per share ("Class A Common Stock"), underlying restricted stock units ("RSUs") granted to the reporting person on April 14, 2023 (the "Grant Date") pursuant to the Issuer's 2021 Incentive Award Plan. The RSUs will vest in full, and an equal number of shares of Class A Common Stock will be deliverable to the reporting person, on the first anniversary of the Grant Date, subject to continued service through such vesting date. F2 · balance_after: Includes 96,281 shares of Class A Common Stock underlying RSUs, which are subject to forfeiture until they vest. Read SEC document
March 31, 2023 Filed Apr 4, 2023 21:31 UTC	ANAVEX LIFE SCIENCES CORP. AVXL · Entity 6086	GrantStock Option (Right to Buy) · Derivative	50,000	$0.00 Strike: $8.57	$0.00	Disclosure SEC source: 0001731122-23-000585 · ownership.xml · derivative · entry 1 Ma Jiong · CIK 0001854872 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2033-03-31 F1 · derivative.exercise_date: Options vest in equal instalments over three years from the grant date Read SEC document
January 06, 2023 Filed Dec 26, 2023 22:58 UTC	MOBIX LABS, INC MOBX · Entity 7651	OtherClass A Common Stock	20,000	$0.00	$0.00	Disclosure SEC source: 0001104659-23-129310 · tm2333669-17_4seq1.xml · nonDerivative · entry 2 Ma Jiong · CIK 0001854872 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 1,580,813 F1 · security: Pursuant to the Issuer's de-registration as a Cayman Islands exempted company and domestication as a Delaware corporation (the "Domestication") in connection with the closing (the "Closing") of the Issuer's initial business combination (the "Business Combination"; the Issuer prior to the Domestication, "Chavant") with Mobix Labs, Inc. (the "Target") on December 21, 2023, each ordinary share of Chavant ("Ordinary Share") and each private placement warrant, exercisable to purchase one Ordinary Share for $11.50 per share, subject to certain adjustments, of Chavant ("Chavant Private Placement Warrants") was automatically converted into one share of Class A Common Stock of the Issuer ("Class A Common Stock") and one private placement warrant, exercisable to purchase one share of Class A Common Stock for $11.50 per share, subject to certain adjustments, of the Issuer ("Private Placement Warrants"), respectively. In connection with the Closing, Chavant was renamed "Mobix Labs, Inc." F2 · kind: Represents a transfer of interests in Chavant Capital Partners LLC (the "Sponsor") by the Reporting Person to another member of the Sponsor in connection with such other member's agreement to fund certain amounts to the Sponsor in order to permit it to make certain loans to the Issuer. Does not represent any transfer of Ordinary Shares then held by the Sponsor, and prior to and following such transfers, the Sponsor continued to hold 1,580,813 Ordinary Shares. F2 · balance_after: Represents a transfer of interests in Chavant Capital Partners LLC (the "Sponsor") by the Reporting Person to another member of the Sponsor in connection with such other member's agreement to fund certain amounts to the Sponsor in order to permit it to make certain loans to the Issuer. Does not represent any transfer of Ordinary Shares then held by the Sponsor, and prior to and following such transfers, the Sponsor continued to hold 1,580,813 Ordinary Shares. F3 · ownership.nature: The Sponsor is the record holder of the securities reported herein. The Reporting Person is the sole member of the manager of the Sponsor and has voting and investment discretion with respect to the securities held of record by the Sponsor. The Reporting Person disclaims any beneficial ownership of the securities held by the Sponsor other than to the extent of any pecuniary interest she may have therein, directly or indirectly. Read SEC document
October 10, 2022 Filed Dec 26, 2023 22:58 UTC	MOBIX LABS, INC MOBX · Entity 7651	OtherClass A Common Stock	19,000	$0.00	$0.00	Disclosure SEC source: 0001104659-23-129310 · tm2333669-17_4seq1.xml · nonDerivative · entry 1 Ma Jiong · CIK 0001854872 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 1,580,813 F1 · security: Pursuant to the Issuer's de-registration as a Cayman Islands exempted company and domestication as a Delaware corporation (the "Domestication") in connection with the closing (the "Closing") of the Issuer's initial business combination (the "Business Combination"; the Issuer prior to the Domestication, "Chavant") with Mobix Labs, Inc. (the "Target") on December 21, 2023, each ordinary share of Chavant ("Ordinary Share") and each private placement warrant, exercisable to purchase one Ordinary Share for $11.50 per share, subject to certain adjustments, of Chavant ("Chavant Private Placement Warrants") was automatically converted into one share of Class A Common Stock of the Issuer ("Class A Common Stock") and one private placement warrant, exercisable to purchase one share of Class A Common Stock for $11.50 per share, subject to certain adjustments, of the Issuer ("Private Placement Warrants"), respectively. In connection with the Closing, Chavant was renamed "Mobix Labs, Inc." F2 · kind: Represents a transfer of interests in Chavant Capital Partners LLC (the "Sponsor") by the Reporting Person to another member of the Sponsor in connection with such other member's agreement to fund certain amounts to the Sponsor in order to permit it to make certain loans to the Issuer. Does not represent any transfer of Ordinary Shares then held by the Sponsor, and prior to and following such transfers, the Sponsor continued to hold 1,580,813 Ordinary Shares. F2 · balance_after: Represents a transfer of interests in Chavant Capital Partners LLC (the "Sponsor") by the Reporting Person to another member of the Sponsor in connection with such other member's agreement to fund certain amounts to the Sponsor in order to permit it to make certain loans to the Issuer. Does not represent any transfer of Ordinary Shares then held by the Sponsor, and prior to and following such transfers, the Sponsor continued to hold 1,580,813 Ordinary Shares. F3 · ownership.nature: The Sponsor is the record holder of the securities reported herein. The Reporting Person is the sole member of the manager of the Sponsor and has voting and investment discretion with respect to the securities held of record by the Sponsor. The Reporting Person disclaims any beneficial ownership of the securities held by the Sponsor other than to the extent of any pecuniary interest she may have therein, directly or indirectly. Read SEC document
June 27, 2022 Filed Jun 29, 2022 21:08 UTC	ANAVEX LIFE SCIENCES CORP. AVXL · Entity 6086	GrantStock Option (Right to Buy) · Derivative	50,000	$0.00 Strike: $10.09	$0.00	Disclosure SEC source: 0001731122-22-001141 · ownership.xml · derivative · entry 1 Ma Jiong · CIK 0001854872 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2032-06-27 Read SEC document
April 18, 2022 Filed Apr 21, 2022 00:22 UTC	SES AI Corp SES · Entity 2220	GrantClass A Common Stock	33,519	$0.00	$0.00	Disclosure SEC source: 0000899243-22-015243 · doc4.xml · nonDerivative · entry 1 Ma Jiong · CIK 0001854872 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,519 F1 · shares: Represents shares of Class A common stock, par value $0.0001 per share ("Class A Common Stock"), underlying restricted stock units ("RSUs") granted to the reporting person on April 18, 2022 (the "Grant Date") pursuant to the Issuer's 2021 Incentive Award Plan. The RSUs will vest in full, and an equal number of shares of Class A Common Stock will be deliverable to the reporting person, on the first anniversary of the Grant Date, subject to continued service through such vesting date. Read SEC document
February 24, 2022 Filed Feb 28, 2022 16:44 UTC	MOBIX LABS, INC CLAY · Entity 7651	GrantOrdinary Shares	18,782	$0.00	$0.00	Disclosure SEC source: 0001104659-22-027835 · tm227631-6_4.xml · nonDerivative · entry 1 Ma Jiong · CIK 0001854872 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 1,580,814 F1 · shares: The ordinary shares are described under the heading "Description of Securities" in the Issuer's Registration Statement on Form S-1 (File No. 333-257459) (the "Registration Statement") and have no expiration date. On February 24, 2022, the Reporting Person acquired 18,782 ordinary shares from certain directors and officers of Chavant Capital Acquisition Corp. for no consideration. F1 · price: The ordinary shares are described under the heading "Description of Securities" in the Issuer's Registration Statement on Form S-1 (File No. 333-257459) (the "Registration Statement") and have no expiration date. On February 24, 2022, the Reporting Person acquired 18,782 ordinary shares from certain directors and officers of Chavant Capital Acquisition Corp. for no consideration. F2 · ownership.nature: Chavant Capital Partners LLC is the record holder of the securities reported herein. Jiong Ma is the manager of Chavant Capital Partners LLC and has voting and investment discretion with respect to the securities held of record by Chavant Capital Partners LLC. Dr. Ma disclaims any beneficial ownership of the securities held by Chavant Capital Partners LLC other than to the extent of any pecuniary interest she may have therein, directly or indirectly. Read SEC document
September 20, 2021 Filed Sep 21, 2021 23:45 UTC	MOBIX LABS, INC CLAY · Entity 7651	Disposition to issuerOrdinary Shares	255,903	$0.00	$0.00	Disclosure SEC source: 0001104659-21-118023 · tm2128151-1_4.xml · nonDerivative · entry 1 Ma Jiong · CIK 0001854872 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 1,562,032 F1 · shares: The ordinary shares are described under the heading "Description of Securities" in the Issuer's Registration Statement on Form S-1 (File No. 333-257459) (the "Registration Statement") and have no expiration date. On September 20, 2021, in connection with the expiration of the underwriters' over-allotment option originally granted to the underwriters in connection with the Issuer's initial public offering of units, as described in the Registration Statement, the Reporting Person surrendered 255,903 ordinary shares to the Issuer. F1 · price: The ordinary shares are described under the heading "Description of Securities" in the Issuer's Registration Statement on Form S-1 (File No. 333-257459) (the "Registration Statement") and have no expiration date. On September 20, 2021, in connection with the expiration of the underwriters' over-allotment option originally granted to the underwriters in connection with the Issuer's initial public offering of units, as described in the Registration Statement, the Reporting Person surrendered 255,903 ordinary shares to the Issuer. F2 · ownership.nature: Chavant Capital Partners LLC is the record holder of the securities reported herein. Jiong Ma is the manager of Chavant Capital Partners LLC and has voting and investment discretion with respect to the securities held of record by Chavant Capital Partners LLC. Ms. Ma disclaims any beneficial ownership of the securities held by Chavant Capital Partners LLC other than to the extent of any pecuniary interest she may have therein, directly or indirectly. Read SEC document
August 02, 2021 Filed Aug 4, 2021 21:40 UTC	ANAVEX LIFE SCIENCES CORP. AVXL · Entity 6086	GrantStock Option (Right to Buy) · Derivative	25,000	$0.00 Strike: $18.11	$0.00	Disclosure SEC source: 0001731122-21-001306 · ownership.xml · derivative · entry 1 Ma Jiong · CIK 0001854872 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2031-08-02 Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.